Recent adaptive selection at MAOB and ancestral susceptibility to schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 3, 2009, Pages 369-374

  Carrera, Noa ^a   Sanjuán, Julio ^b   Moltó, María Dolores ^c   Carracedo, Ángel ^a,d   Costas, Javier ^a,e  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Centro Nacional de Genotipado (CeGen)   (Spain)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

Case control studies; Common disease common variant hypothesis; Dopaminergic hypothesis; Monoamine oxidase; Natural selection

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, X; COHORT STUDIES; CONFIDENCE INTERVALS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GEOGRAPHY; HAPLOTYPES; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MONOAMINE OXIDASE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SELECTION (GENETICS); SPAIN;

EID: 63449115452     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30823     Document Type: Article

References (46)

1. AbramsonJH. 2004. WINPEPI (PEPI-for-Windows): Computer programs for epidemiologists. Epidemiol Perspect Innov 1(1):6.
2. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC. et al. 1999. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry 56(2):162-168.
3. Coron B, Campion D, Thibaut F, Dollfus S, Preterre P, Langlois S, Vasse T, Moreau V, Martin C, Charbonnier F, et al. 1996. Association study between schizophrenia and monoamine oxidase A and B DNA polymorphisms. Psychiatry Res 62(3):221-226.
4. Costas J, Salas A, Phillips C, Carracedo A. 2005. Human genome-wide screen of haplotype-like blocks of reduced diversity. Gene 349:219-225.
5. Craddock N, O'Donovan MC, Owen MJ. 2007. Phenotypic and genetic complexity of psychosis. Invited commentary on Schizophrenia: A common disease caused by multiple rare alleles. Br J Psychiatry 190: 200-203.
6. Crespi B, Summers K, Dorus S. 2007. Adaptive evolution of genes underlying schizophrenia. Proc Biol Sci 274(1627):2801-2810.
7. Crow T. 2007. Genetic hypotheses for schizophrenia. Br J Psychiatry 191180; author reply 180-1.
8. Cyr M, Calon F, Morissette M, Grandbois M, Di Paolo T, Callier S. 2000. Drugs with estrogen-like potency and brain activity: Potential therapeutic application for the CNS. Curr Pharm Des 6(12):1287-1312.
9. Di Rienzo A. 2006. Population genetics models of common diseases. Curr Opin Genet Dev 16(6):630-636.
10. Di Rienzo A, Hudson RR. 2005. An evolutionary framework for common diseases: The ancestral-susceptibility model. Trends Genet 21(11): 596-601.
11. Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR, Kidd KK, Flodman P, Spence MA, Schuck S, Swanson JM, et al. 2002. Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci USA 99(1):309-314.
12. Gilad Y, Rosenberg S, Przeworski M, Lancet D, Skorecki K. 2002. Evidence for positive selection and population structure at the human MAO-A gene. Proc Natl Acad Sci USA 99(2):862-867.
13. Gundlah C, Lu NZ, Bethea CL. 2002. Ovarian steroid regulation of monoamine oxidase-A and-B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 160(3):271-282.
14. Halbreich U, Kahn LS. 2003. Hormonal aspects of schizophrenias: An overview. Psychoneuroendocrinology 28(Suppl 2):1-16.
15. Haukka J, Suvisaari J, Lonnqvist J. 2003. Fertility of patients with schizophrenia, their siblings, and the general population: A cohort study from 1950 to 1959 in Finland. Am J Psychiatry 160(3):460-463.
16. Hawks J, Wang ET, Cochran GM, Harpending HC, Moyzis RK. 2007.
17. Recent acceleration of human adaptive evolution. Proc Natl Acad Sci USA 104(52):20753-20758.
18. Hoogendoorn ML, Bakker SC, Schnack HG, Selten JP, Otten HG, Verduijn W, van der Heijden FM, Pearson PL, Kahn RS, Sinke RJ. 2005. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am J Med Genet B Neuropsychiatr Genet 134(1):6-9.
19. Huxley J, Mayr E, Osmond H, Hoffer A. 1964. Schizophrenia as a Genetic Morphism. Nature 204:220-221.
20. Iversen SD, Iversen LL. 2007. Dopamine: 50 years in perspective. Trends Neurosci 30(5):188-193.
21. Keller MC, Miller G. 2006. Resolving the paradox of common, harmful, heritable mental disorders: Which evolutionary genetic models work best? Behav Brain Sci 29(4):385-404; discussion 405-52.
22. Kelley JL, Madeoy J, Calhoun JC, Swanson W, Akey JM. 2006. Genomicsignatures of positive selection in humans and the limits of outlier approaches. Genome Res 16(8):980-989.
23. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, Kucher-lapati R, Malhotra AK. 2007. Converging evidence for a pseudoautoso-mal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12(6):572-580.
24. Lo WS, Xu Z, Yu Z, Pun FW, Ng SK, Chen J, Tong KL, Zhao C, Xu X, Tsang SY, et al. 2007. Positive selection within the Schizophrenia-associated GABA(A) receptor beta2 gene. PLoS ONE 2(5):e462.
25. McClellan JM, Susser E, King MC. 2007a. Schizophrenia: A common disease caused by multiple rare alleles. Br J Psychiatry 190:194-199.
26. McClellan JM, Susser E, King MC. 2007b. Authors' reply to: Genetic hypotheses for schizophrenia. Br J Psychiatry 191:180-181.
27. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ. et al. 2002. Detecting recent positive selection in the human genome from haplotype structure. Nature 419(6909):832-837.
28. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, Palma A, Mikkelsen TS, Altshuler D, Lander ES. 2006. Positive natural selection in the human lineage. Science 312(5780):1614-1620.
29. Saha S, Chant D, Welham J, McGrath J. 2005. A systematic review of the prevalence of schizophrenia. PLoS Med 2(5):e141.
30. Saha S, Chant D, McGrath J. 2007. A systematic review of mortality in schizophrenia: Is thedifferentialmortalitygap worseningovertime?Arch Gen Psychiatry 64(10):1123-1131.
31. Salem JE, Kring AM. 1998. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin Psychol Rev 18(7): 795-819.
32. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, Burrell GJ, Rice JP, Nertney DA, Olincy A. et al. 2008. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: Implications for psychiatric genetics. Am J Psychiatry 165: 497-506.
33. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L. et al. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71(6):1296-1302.
34. Shih JC, Chen K, Ridd MJ. 1999. Monoamine oxidase: From genes to behavior. Annu Rev Neurosci 22:197-217.
35. Snell LD, Glanz J, Tabakoff B. 2002. Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: Activity, affinity labeling, and protein measurements. Alcohol Clin Exp Res 26(7):1105-1113.
36. Strolin Benedetti M, Tipton KF, Whomsley R. 2007. Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: Has the involvement of amine oxidases been neglected? Fundam Clin Pharmacol 21(5):467-480.
37. Suvisaari J, Hakkinen L, Haukka J, Lonnqvist J. 2007. Mortality in offspring of mothers with psychotic disorder. Psychol Med: 1-8 (in press). DOI:10.1017/S0033291707002383.
38. Talkowski ME, Bamne M, Mansour H, Nimgaonkar VL. 2007. Dopamine genes and schizophrenia: Case closed or evidence pending? Schizophr Bull 33(5):1071-1081.
39. The International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437(7063):1299-1320.
40. The International HapMap Consortium. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164): 851-861.
41. Vallender EJ, Lahn BT. 2004. Positive selection on the human genome. Hum Mol Genet 13(SpecNo 2):R245-R254.
42. Voight BF, Kudaravalli S, Wen X, Pritchard JK. 2006. A map of recent positive selection in the human genome. PLoS Biol 4(3):e72.
43. Wang ET, Kodama G, Baldi P, Moyzis RK. 2006. Global landscape ofrecent inferred Darwinian selection for Homo sapiens. Proc Natl Acad Sci USA 103(1):135-140.
44. Wei J, Hemmings GP. 1999. A study of linkage disequilibrium between polymorphic loci for monamine oxidases A and B in schizophrenia. Psychiatr Genet 9(4):177-181.
45. WintererG, Weinberger DR. 2004. Genes, dopamineandcorticalsignal-to-oise ratio in schizophrenia. Trends Neurosci 27(11):683-690.
46. Xie T, Ho SL, Ramsden D. 1999. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56(1):31-38.